|
⚲
|
| DOR Biopharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000812796 |
| Sale | 2009-03-06 ($0.4 M Offered, $0.3 M Sold) |
| Fund | |
| Phone | 6095388200 |
| Address | 850 Bear Tavern Road Ewing, 08628 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Evan Myrainthopoulos | |
| Christopher Schaber | |
| Cyrille Buhrman | |
| Greg Lapointe | |
| James Clavijo | |
| Evan Myrianthopoulos | |
| Robert Brey | |
| James Kuo | |
| Brian Hamilton |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Dianthus Therapeutics, Inc. /DE/
✚
|
0.0 | |
|
Diaz Allene M.
✚
|
0.0 | |
|
Diaz Deborah
✚
|
0.0 | |
|
Diaz Fred M
✚
|
0.0 | |
|
Dickason Allen Charles
✚
|
0.0 | |
|
Dick Barry
✚
|
0.0 | |
|
Dickens Zachary T
✚
|
0.0 | |
|
Dickerman Jeffrey F
✚
|
0.0 | |
|
Dickins Denise
✚
|
0.0 | |
|
Mount Elbert 14 440 LLC
✚
|
0.0 |